Molecular cloning and functional characterization of the pig analogue of CD59: Relevance to xenotransplantation

Journal of Immunology

Volumn 160, Issue 8, 1998, Pages 3924-3932

  Hinchliffe, Stewart J ^a   Rushmere, Neil K ^a   Hanna, S Melanie ^a   Morgan, B Paul ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD59 ANTIGEN; GLYCOSYLPHOSPHATIDYLINOSITOL; SIGNAL PEPTIDE;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; DNA SEQUENCE; ERYTHROCYTE; GENE AMPLIFICATION; GENE EXPRESSION; GLYCOSYLATION; MOLECULAR CLONING; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SWINE; XENOTRANSPLANTATION;

AMINO ACID SEQUENCE; ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANTIGENS, CD59; BASE SEQUENCE; CELL LINE; CLONING, MOLECULAR; COMPLEMENT INACTIVATOR PROTEINS; DNA PRIMERS; DNA, COMPLEMENTARY; ERYTHROCYTES; GENE EXPRESSION; GENETIC ENGINEERING; HUMANS; MICE; MOLECULAR SEQUENCE DATA; RATS; SEQUENCE HOMOLOGY, AMINO ACID; SPECIES SPECIFICITY; SWINE; TRANSFECTION; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION, HETEROLOGOUS;

EID: 0032522659     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Davies, A., D. L. Simmons, G. Hale, R. A. Harrison, H. Tighe, P. J. Lachmann, and H. Waldmann. 1989. CD59, an LY6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells. J. Exp. Med. 170:637.
2. Okada, N., R. Harada, T. Fujita, and H. Okada. 1989. A novel membrane glycoprotein capable of inhibiting membrane attack by homologous complement. Int. Immunol. 1:205.
3. Sugita, Y., Y. Nakano, and M. Tomita. 1988. Isolation from human erythrocytes of a new membrane protein which inhibits the formation of complement transmembrane channels. J. Biochem. 104:633.
4. Okada, H., Y. Nagami, K. Takahashi, N. Okada, T. Hideshima, H. Takizawa, and J. Kondo. 1989. 20kDa homologous restriction factor of complement resembles T-cell activating protein. Biochem. Biophys. Res. Commun. 162:1553.
5. Ninoyima, H., and P. J. Sims. 1992. The human complement regulatory protein CD59 binds to the alpha chain of C8 and to the "b" domain of C9. J. Biol. Chem. 267:13675.
6. Meri, S., B. P. Morgan, A. Davies, R. H. Daniels, M. G. Olavesen, H. Waldmann, and P. J. Lachmann. 1990. Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalyzed insertion of C9 into lipid bilayers. Immunology 71:1.
7. Rollins, S. A., J. Zhao, H. Ninoyima, and P. J. Sims. 1991. Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9. J. Immunol. 146:2345.
8. Hughes, T. R., S. J. Piddlesden, J. D. Williams, R. A. Harrison, and B. P. Morgan. 1992. Isolation and characterization of a membrane protein from rat erythrocytes which inhibits lysis by the membrane attack complex of rat complement. Biochem. J. 284:169.
9. Van den Berg, C. W., R. A. Harrison, and B. P. Morgan. 1993. The sheep analogue of human CD59: purification and characterization of its complement inhibitory activity. Immunology 78:349.
10. Van den Berg, C. W., R. A. Harrison, and B. P. Morgan. 1995. A rapid method for the isolation of analogues of human CD59 by preparative SDS-PAGE: application to pig CD59. J. Immunol. Methods 179:223.
11. Van den Berg, C. W., and B. P. Morgan. 1994. Complement-inhibiting activities of human CD59 and analogues from rat, sheep and pig are not homologously restricted. J. Immunol. 152:4095.
12. Rushmere, N. K., R. A. Harrison, C. W. van den Berg, and B. P. Morgan. 1994. Molecular cloning of the rat analogue of human CD59: structural comparison with human CD59 and identification of a putative active site. Biochem. J. 304: 595.
13. Powell, M. B., K. J. Marchbank, N. K. Rushmere, C. W. van den Berg, and B. P. Morgan. 1997. Molecular cloning, chromosomal localization, expression and functional characterization of the mouse analogue of human CD59. J. Immunol. 158:1692.
14. Bodian, D. L., S. J. Davis, B. P. Morgan, and N. K. Rushmere. 1997. Mutational analysis of the active site and antibody epitopes of the complement-inhibitory glycoprotein, CD59. J. Exp. Med. 185:507.
15. Yu, J., S. Dong, N. K. Rushmere, B. P. Morgan, R. Abagayan, and S. Tomlinson. 1997. Mapping the regions of the complement inhibitor CD59 responsible for its species selective activity. Biochemistry 36:9423.
16. White, D. J. G. 1992. Transplantation of organs between species. Int. Arch. Allergy Appl. Immunol. 98:1.
17. 1,3)Gal epitopes. Proc. Natl. Acad. Sci. USA 90:11391.
18. (1,3)-galactosyltransferase. J. Biol. Chem. 265:7055.
19. Kennedy, S. P., S. A. Rollins, W. V. Burton, P. J. Sims, A. L. M. Bothwell, S. P. Squinto, and G. B. Zavoico. 1994. Protection of porcine aortic endothelial cells from complement-mediated cell lysis and activation by recombinant human CD59. Transplantation 57:1494.
20. HecklOstreicher, B., R. Binder, and M. Kirschfink. 1995. Functional activity of the membrane-associated complement inhibitor CD59 in a pig-to-human in vitro model for hyperacute xenograft rejection. Clin. Exp. Immunol. 102:589.
21. HecklOstreicher, B., A. Wosnik, and M. Kirschfink. 1996. Protection of porcine endothelial cells from complement-mediated cytotoxicity by the human complement regulators CD59, C1 inhibitor, and soluble complement receptor type 1: analysis in a pig-to-human in vitro model relevant to hyperacute xenograft rejection. Transplantation 62:1693.
22. Carrington, C. A., A. C. Richards, E. Cozzi, G. Langford, N. Yannoutsos, and D. J. G. White. 1995. Expression of human DAF and MCP on pig endothelial cells protects from human complement. Transplant. Proc. 27:321.
23. Fodor, W. L., B. L. Williams, L. A. Matis, J. A. Madri, S. A. Rollins, J. W. Knight, W. Velander, and S. P. Squinto. 1994. Expression of a functional human complement inhibitor in a transgenic pig as a model for the prevention of a xenogeneic hyperacute organ rejection. Proc. Natl. Acad. Sci. USA 91:11153.
24. Langford, G. A., N. Yannoutsos, E. Cozzi, R. Lancaster, K. Elsome, P. Chen, A. Richards, and D. J. G. White. 1994. Production of pigs transgenic for human decay accelerating factor. Transplant. Proc. 26:1400.
25. Rosengard, A. M., N. R. B. Cary, G. A. Langford, A. W. Tucker, J. Wallwork, and D. J. G. White. 1995. Tissue expression of human complement inhibitor, decay accelerating factor, in transgenic pigs: a potential approach for preventing xenograft rejection. Transplantation 59:1325.
26. Diamond, L. E., K. R. McCurry, M. J. Martin, S. B. McClellan, E. R. Oldham, J. L. Platt, and J. S. Logan. 1996. Characterization of transgenic pigs expressing functionally active human CD59 on cardiac endothelium. Transplantation 61: 1241.
27. Byrne, G., K. McCurry, M. Martin, J. Platt, and J. Logan. 1996. Development and analysis of transgenic pigs expressing the human complement regulatory proteins CD59 and DAF. Transplant. Proc. 28:759.
28. Kroshus, T. J., R. M. Bolman III, A. P. Dalmasso, S. A. Rollins, E. R. Guilmette, B. L. Williams, S. P. Squinto, and W. L. Fodor. 1996. Expression of human CD59 in transgenic pig organs enhances organ survival in an ex vivo xenogeneic perfusion model. Transplantation 61:1513.
29. Pascher, A., C. Poehlein, M. Storck, D. Aendroth, J. MuellerHoecker, W. Koenig, V. K. Young, D. J. G. White, and C. Hammer. 1996. Expression of human decay accelerating factor (hDAF) in transgenic pigs regulates complement activation during ex vivo liver perfusion: immunopathological findings. Transpl. Int. 9:S385.
30. Storck, M., D. Abendroth, R. Prestel, G. PinoChavez, J. MullerHoker, D. J. G. White, and C. Hammer. 1997. Morphology of hDAF (CD55) transgenic pig kidneys following ex vivo hemoperfusion with human blood. Transplantation 63:304.
31. McCurry, K. R., D. L. Kooyman, C. G. Alvarado, A. M. Cotterell, M. J. Martin, J. S. Logan, and J. L. Platt. 1995. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nat. Med. 1:423.
32. Byrne, G. W., K. R. McCurry, M. J. Martin, S. M. McClellan, J. L. Platt, and J. S. Logan. 1997. Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage. Transplantation 63:149.
33. + subclone of the U937 cell line. Immunology 81:637.
34. Don, R. H., P. T. Cox, P. J. Wainwright, K. Baker, and J. S. Mattick. 1991. "Touchdown" PCR to circumvent spurious priming during gene amplification. Nucleic Acids Res. 19:4008.
35. Frohman, M. A. 1990. PCR Protocols: A Guide to Methods and Applications. Academic Press, London, pp. 28-38.
36. Charreau, B., A. Cassard, L. Tesson, B. Le Mauff, J.-M. Navenot, D. Blanchard, D. Lublin, J.-P. Soulillou, and I. Anegon. 1994. Protection of rat endothelial cells from primate complement-mediated lysis by expression of human CD59 and/or decay accelerating factor. Transplantation 58:1222.
37. Mizushima, S., and S. Nagata. 1990. pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res. 18:5322.
38. Gerber, L. D., K. Kodukula, and S. Udenfriend. 1992. Phosphatidylinositol glycan (PI-G) anchored membrane proteins: amino acid requirements adjacent to the site of cleavage and PI-G attachment in the COOH-terminal signal peptide. J. Biol. Chem. 267:12168.
39. Philbrick, W. M., R. G. E. Palfree, S. E. Maher, M. M. Bridgett, S. Sirlin, and A. L. M. Bothwell. 1990. The CD59 antigen is a structural homologue of murine Ly-6 antigens but lacks interferon inducibility. Eur. J. Immunol. 20:87.
40. Sawada, R., K. Ohashi, H. Anaguchi, H. Okazaki, M. Hattori, N. Minato, and M. Naruto. 1990. Isolation and expression of the full length cDNA encoding CD59 antigen of human lymphocytes. DNA Cell Biol. 9:213.
41. Tone, M., L. A. Walsh, and H. Waldmann. 1992. Gene structure of human CD59 and demonstration that discrete mRNAs are generated by alternative polyadenylation. J. Mol. Biol. 227:971.
42. Quigg, R. J., B. P. Morgan, V. M. Holers, S. Adler, A. E. Sneed III, and C. F. Lo. 1995. Complement regulation in the rat glomerulus: Crry and CD59 regulate complement in glomerular mesangial and endothelial cells. Kidney Int. 48:412.
43. Fletcher, C. M., R. A. Harrison, P. J. Lachmann, and D. Neuhaus. 1994. Structure of a soluble, glycosylated form of the complement regulatory protein CD59. Structure 2:185.
44. Tripathy, S. K., E. Goldwasser, M.-M. Lu, E. Barr, and J. M. Leiden. 1994. Stable delivery of physiologic levels of recombinant erythropoietin to the systemic circulation by intramuscular injection of replication-defective adenovirus. Proc. Natl. Acad. Sci. USA 91:11557.
45. Van den Berg, C. W., J. M. Perez de la Lastra, D. Llanes, and B. P. Morgan. 1997. Purification and characterization of the pig analogue of human membrane cofactor protein (CD46/MCP). J. Immunol. 158:1703.